Fig 1.
Flow chart of the study protocol.
Table 1.
General characteristics of the patients included (n = 159).
Table 2.
Most frequently identified potential drug–drug interactions based on severity and their associated monitoring methods in the pediatric intensive care unit.
Table 3.
Most frequently identified potential drug–drug interactions by department.
Table 4.
Clinically relevant potential drug–drug interactions: adverse event, causality, severity, and management.
Table 5.
Risk factors associated with potential drug–drug interactions and clinically relevant potential drug–drug interactions.